The recent approval of two new drugs, Leqembi and Kisunla, by the FDA has sparked optimism among families affected by Alzheimer’s disease and mild cognitive impairment...
The U.S. Food and Drug Administration (FDA) is preparing to implement additional deregulation measures, as indicated by Commissioner Marty Makary. In statements made this week, Makary...
The Food and Drug Administration (FDA) has unveiled a significant initiative aimed at simplifying the approval process for biosimilars, which are cheaper alternatives to biologic drugs....
The Food and Drug Administration (FDA) has announced a new initiative aimed at accelerating the approval process for biosimilar drugs, which are less expensive alternatives to...
Publix Super Markets has initiated a voluntary recall of its Publix Rich & Creamy Vanilla Ice Cream due to the presence of an undeclared egg allergen,...
The U.S. Food and Drug Administration (FDA) has announced the first group of drugs that will undergo expedited review processes. This initiative is part of a...
Concerns are mounting over the United States’ heavy dependence on foreign-made generic drugs, particularly following reports linking this reliance to the deaths of over 100 individuals....
Namandje Bumpus, the former principal deputy commissioner of the U.S. Food and Drug Administration (FDA), has been appointed to lead a new scientific advisory board at...
Namandje Bumpus, the former principal deputy commissioner of the U.S. Food and Drug Administration (FDA), has been appointed to lead a new scientific advisory board at...
The US Food and Drug Administration (FDA) has granted clearance to a new blood test designed to assist in assessing the likelihood of Alzheimer’s disease in...
